These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29352113)

  • 1. Polo-like kinase 4 mediates epithelial-mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway.
    Tian X; Zhou D; Chen L; Tian Y; Zhong B; Cao Y; Dong Q; Zhou M; Yan J; Wang Y; Qiu Y; Zhang L; Li Z; Wang H; Wang D; Ying G; Zhao Q
    Cell Death Dis; 2018 Jan; 9(2):54. PubMed ID: 29352113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma.
    Li M; Sun C; Bu X; Que Y; Zhang L; Zhang Y; Zhang L; Lu S; Huang J; Zhu J; Wang J; Sun F; Zhang Y
    Cell Death Dis; 2021 Jun; 12(6):620. PubMed ID: 34131100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydroeffusol inhibits viability and epithelial-mesenchymal transition through the Hedgehog and Akt/mTOR signaling pathways in neuroblastoma cells.
    He K; Duan G; Li Y
    Eur J Pharmacol; 2018 Jun; 829():93-101. PubMed ID: 29665365
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Jin Q; Chen Y; Du S; Xu D; Yue J; Cai L; Yuan X
    Curr Cancer Drug Targets; 2022; 22(11):919-930. PubMed ID: 35909289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fraxetin down-regulates polo-like kinase 4 (PLK4) to inhibit proliferation, migration and invasion of prostate cancer cells through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) pathway.
    Ma Z; Sun Y; Peng W
    Bioengineered; 2022 Apr; 13(4):9345-9356. PubMed ID: 35387563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polo-Like Kinase 4 (PLK4) Is Overexpressed in Central Nervous System Neuroblastoma (CNS-NB).
    Bailey AW; Suri A; Chou PM; Pundy T; Gadd S; Raimondi SL; Tomita T; Sredni ST
    Bioengineering (Basel); 2018 Nov; 5(4):. PubMed ID: 30400339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of MEG3 promotes neuroblastoma development through FOXO1-mediated autophagy and mTOR-mediated epithelial-mesenchymal transition.
    Ye M; Lu H; Tang W; Jing T; Chen S; Wei M; Zhang J; Wang J; Ma J; Ma D; Dong K
    Int J Biol Sci; 2020; 16(15):3050-3061. PubMed ID: 33061817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3K Inhibitor Combined With Chemotherapy Can Enhance the Apoptosis of Neuroblastoma Cells In Vitro and In Vivo.
    Geng X; Xie L; Xing H
    Technol Cancer Res Treat; 2016 Oct; 15(5):716-22. PubMed ID: 26224681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEST-containing nuclear protein mediates the proliferation, migration, and invasion of human neuroblastoma cells through MAPK and PI3K/AKT/mTOR signaling pathways.
    Wu DD; Gao YR; Li T; Wang DY; Lu D; Liu SY; Hong Y; Ning HB; Liu JP; Shang J; Shi JF; Wei JS; Ji XY
    BMC Cancer; 2018 May; 18(1):499. PubMed ID: 29716528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-203 inhibits the malignant progression of neuroblastoma by targeting Sam68.
    Zhao D; Tian Y; Li P; Wang L; Xiao A; Zhang M; Shi T
    Mol Med Rep; 2015 Oct; 12(4):5554-60. PubMed ID: 26136151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
    Li Z; Jaboin J; Dennis PA; Thiele CJ
    Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway.
    Yin XF; Zhang Q; Chen ZY; Wang HF; Li X; Wang HX; Li HX; Kang CM; Chu S; Li KF; Li Y; Qiu YR
    Int J Oncol; 2018 Sep; 53(3):973-986. PubMed ID: 30015880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Polo-like kinase 4 induces cell apoptosis and G2/M arrest in acute myeloid leukemia.
    Chen S; Zhong L; Chu X; Wan P; Liu Z; Lu Y; Zhang Z; Wang X; Zhou Z; Shao X; Liu B
    Pathol Res Pract; 2023 Mar; 243():154376. PubMed ID: 36821942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.
    Bieerkehazhi S; Chen Z; Zhao Y; Yu Y; Zhang H; Vasudevan SA; Woodfield SE; Tao L; Yi JS; Muscal JA; Pang JC; Guan S; Zhang H; Nuchtern JG; Li H; Li H; Yang J
    Oncotarget; 2017 Jan; 8(1):1469-1480. PubMed ID: 27903968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polo-like kinase 4 (Plk4) potentiates anoikis-resistance of p53KO mammary epithelial cells by inducing a hybrid EMT phenotype.
    Fonseca I; Horta C; Ribeiro AS; Sousa B; Marteil G; Bettencourt-Dias M; Paredes J
    Cell Death Dis; 2023 Feb; 14(2):133. PubMed ID: 36797240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Polo-Like Kinase 4 (PLK4) in Epithelial Cancers and Recent Progress in its Small Molecule Targeting for Cancer Management.
    Garvey DR; Chhabra G; Ndiaye MA; Ahmad N
    Mol Cancer Ther; 2021 Apr; 20(4):632-640. PubMed ID: 33402398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.